Neuroscientific Biopharmaceuticals (ASX:NSB) ROE % Adjusted to Book Value : -34.24% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Neuroscientific Biopharmaceuticals ROE % Adjusted to Book Value?

Neuroscientific Biopharmaceuticals's ROE % for the quarter that ended in Dec. 2023 was -57.86%. Neuroscientific Biopharmaceuticals's PB Ratio for the quarter that ended in Dec. 2023 was 1.69. Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -34.24%.

Neuroscientific Biopharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals ROE % Adjusted to Book Value Chart

Neuroscientific Biopharmaceuticals Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

-15.11

-16.31

-10.62

-21.88

-8.65

Neuroscientific Biopharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial							-19.29	-25.84	-22.56	44.35	-34.24

Competitive Comparison of Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value falls into.

Neuroscientific Biopharmaceuticals ROE % Adjusted to Book Value Calculation

Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-20.93%	/	2.42
	=	-8.65%

Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-57.86%	/	1.69
	=	-34.24%

Neuroscientific Biopharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011

Website

https://www.neuroscientific.com

Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines